Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer

Sponsor
Medical Research Council (Other)
Overall Status
Completed
CT.gov ID
NCT00003014
Collaborator
European Organisation for Research and Treatment of Cancer - EORTC (Other)
800
62
87
12.9
0.1

Study Details

Study Description

Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether chemotherapy is more effective than radiation therapy for testicular cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of carboplatin with that of radiation therapy in treating patients who have stage I testicular cancer.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

OBJECTIVES: I. Compare relapse rates in patients with stage I testicular seminoma treated with adjuvant radiotherapy vs carboplatin. II. Compare quality of life of patients before and after treatment with these regimens. III. Compare the acute and intermediate (1-2 year) side effects of these regimens in these patients. IV. Determine the incidence of late side effects (such as bowel dysfunction) of treatment and second malignancies in these patients.

OUTLINE: This is a randomized study. Patients are randomized to 1 of 2 treatment arms. Arm I:

Patients receive a single dose of carboplatin IV. Arm II: Patients undergo radiotherapy once daily, 5 days a week. Patients are followed every 3 months for 1 year, every 4 months for 1 year, every 6 months for 1 year, and then annually thereafter.

PROJECTED ACCRUAL: Approximately 800 patients will be accrued for this study within 4 years.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
800 participants
Allocation:
Randomized
Primary Purpose:
Treatment
Official Title:
Carboplatin in the Adjuvant Treatment of Stage I Seminoma: A Radomized Comparison of Single Agent Carboplatin With Radiotherapy in the Adjuvant Treatment of Stage I Seminoma of the Testis, Following Orchidectomy
Study Start Date :
Apr 1, 1998
Actual Study Completion Date :
Jul 1, 2005

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No

    DISEASE CHARACTERISTICS: Histologically confirmed stage I seminomatous germ cell tumor of the testis categorized as either "classical" or "anaplastic"

    PATIENT CHARACTERISTICS: Age: 16 and over Performance status: Not specified Hematopoietic:

    Not specified Hepatic: Not specified Renal: Creatinine less than 1.4 mg/dL Other: No concurrent or previously treated malignancy except successfully treated nonmelanoma skin cancer No medical condition or other factor that would preclude study

    PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: No more than 8 weeks since prior orchidectomy Prior inguino-pelvic or scrotal surgery allowed Must be treated with "dog-leg" field if randomized to radiotherapy If prior vasectomy, choice of fields is at the discretion of the clinician

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Porto Alegre Hospital Porto Alegre Rio Grande do Sul Brazil 90035--003
    2 Cancer Care Ontario-London Regional Cancer Centre London Ontario Canada N6A 4L6
    3 Mount Sinai Hospital - Toronto Toronto Ontario Canada M5G 1X5
    4 Princess Margaret Hospital Toronto Ontario Canada M5G 2M9
    5 Hopital Sainte Justine Montreal Quebec Canada H3T 1C5
    6 Maria Hospital Helsinki Finland FIN-0-0180
    7 Antoni van Leeuwenhoekhuis Amsterdam Netherlands 1066 CX
    8 Norwegian Radium Hospital Oslo Norway N-0310
    9 Groote Schuur Hospital, Cape Town Cape Town South Africa 7925
    10 Royal United Hospital Bath England United Kingdom BA1 3NG
    11 University of Birmingham Birmingham England United Kingdom B15 2TT
    12 Children's Hospital - Birmingham UK Birmingham England United Kingdom B16 8ET
    13 Bradford Hospitals NHS Trust Bradford England United Kingdom BD9 6RJ
    14 Royal Sussex County Hospital Brighton England United Kingdom BN2 5BE
    15 Bristol Royal Hospital for Sick Children Bristol England United Kingdom BS2 8BJ
    16 Bristol Haematology and Oncology Centre Bristol England United Kingdom BS2 8ED
    17 Addenbrooke's NHS Trust Cambridge England United Kingdom CB2 2QQ
    18 Kent and Canterbury Hospital Canterbury England United Kingdom CT2 7NR
    19 Walsgrave Hospital Coventry England United Kingdom CV2 2DX
    20 Derbyshire Royal Infirmary Derby England United Kingdom DE1 2QY
    21 Derbyshire Children's Hospital Derby England United Kingdom DE1 3BA
    22 Royal Devon and Exeter Hospital Exeter England United Kingdom EX2 5DW
    23 Gloucester Royal NHS Trust - Glouchester Royal Hospital Gloucester England United Kingdom GL1 3NN
    24 Royal Surrey County Hospital Guildford England United Kingdom GU2 5XX
    25 Royal Free Hospital Hampstead, London England United Kingdom NW3 2QG
    26 Huddersfield Royal Infirmary Huddersfield, West Yorks England United Kingdom HD3 3EA
    27 Cookridge Hospital Leeds England United Kingdom LS16 6QB
    28 St. James's Hospital Leeds England United Kingdom LS9 7TF
    29 University Hospitals of Leicester Leicester England United Kingdom LE1 5WW
    30 Saint Bartholomew's Hospital London England United Kingdom EC1A 7BE
    31 St. Bartholomew's Hospital London England United Kingdom EC1A 7BE
    32 Guy's and St. Thomas' Hospitals Trust London England United Kingdom SE1 7EH
    33 Westminster Hospital London England United Kingdom SW1P 2AP
    34 University College Hospital London England United Kingdom WC1E 6AU
    35 Middlesex Hospital- Meyerstein Institute London England United Kingdom WIT 3AA
    36 Manchester Children's Hospitals (NHS Trust) Manchester England United Kingdom M27 SHA
    37 Clatterbridge Centre for Oncology NHS Trust Merseyside England United Kingdom L63 4JY
    38 South Tees Acute Hospitals NHS Trust Middlesbrough, Cleveland England United Kingdom TS4 3BW
    39 Newcastle General Hospital Newcastle Upon Tyne England United Kingdom NE4 6BE
    40 Newcastle Upon Tyne Hospitals NHS Trust - Freeman Hospital Newcastle-Upon-Tyne England United Kingdom NE7 7DN
    41 Mount Vernon Hospital Northwood England United Kingdom HA6 2RN
    42 Norfolk & Norwich Hospital Norwich England United Kingdom NR1 3SR
    43 Oxford Radcliffe Hospital Oxford England United Kingdom 0X3 9DU
    44 Portsmouth Hospitals NHS Trust Portsmouth England United Kingdom P03 6AD
    45 Children's Hospital - Sheffield Sheffield England United Kingdom S10 2TH
    46 Weston Park Hospital Sheffield England United Kingdom S1O 2SJ
    47 Royal South Hants Hospital Southampton England United Kingdom SO14 0YG
    48 Southampton General Hospital Southampton England United Kingdom SO16 6YD
    49 Royal Marsden Hospital Sutton England United Kingdom SM2 5PT
    50 Princess Royal Hospital Telford England United Kingdom TF6 6TF
    51 Walsall Manor Hospital Walsall England United Kingdom WS2 9PS
    52 Southend NHS Trust Hospital Westcliff-On-Sea England United Kingdom
    53 Royal Belfast Hospital for Sick Children Belfast Northern Ireland United Kingdom BT12 6BE
    54 Aberdeen Royal Infirmary Aberdeen Scotland United Kingdom AB25 2ZN
    55 Ninewells Hospital and Medical School Dundee Scotland United Kingdom DD1 9SY
    56 Western General Hospital Edinburgh Scotland United Kingdom EH4 9NQ
    57 Royal Hospital for Sick Children Edinburgh Scotland United Kingdom
    58 Beatson Oncology Centre Glasgow Scotland United Kingdom G11 6NT
    59 Royal Infirmary Glasgow Scotland United Kingdom G4 0SF
    60 Ysbyty Gwynedd Bangor Wales United Kingdom LL57 2PW
    61 Llandough Hospital Penarth Wales United Kingdom CF6 1XX
    62 Royal Preston Hospital Preston United Kingdom PR2 9HT

    Sponsors and Collaborators

    • Medical Research Council
    • European Organisation for Research and Treatment of Cancer - EORTC

    Investigators

    • Study Chair: Hans Von Der Maase, MD, Aarhus Universitetshospital - Aarhus Sygehus
    • Study Chair: R. T. Oliver, MD, St. Bartholomew's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00003014
    Other Study ID Numbers:
    • CDR0000065594
    • MRC-TE19
    • EORTC-30982
    • EU-97003
    First Posted:
    Mar 12, 2004
    Last Update Posted:
    Dec 4, 2013
    Last Verified:
    Mar 1, 2011

    Study Results

    No Results Posted as of Dec 4, 2013